Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Neil Aggarwal

Concepts (270)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Outpatients
4
2023
326
2.050
Why?
Oxygen
6
2023
854
1.760
Why?
Acute Lung Injury
11
2015
298
1.320
Why?
Macrophages, Alveolar
5
2016
347
1.290
Why?
Pneumonia
6
2018
567
0.980
Why?
T-Lymphocytes, Regulatory
5
2015
339
0.910
Why?
National Heart, Lung, and Blood Institute (U.S.)
6
2021
93
0.740
Why?
Positive-Pressure Respiration
1
2018
68
0.590
Why?
Phagocytes
1
2018
90
0.570
Why?
Oxygen Inhalation Therapy
2
2014
129
0.530
Why?
Lung
12
2018
3558
0.510
Why?
Leukocytes, Mononuclear
1
2018
493
0.490
Why?
Smoke
1
2016
123
0.490
Why?
Receptor, Adenosine A2A
1
2013
20
0.430
Why?
Lipopolysaccharides
9
2015
821
0.410
Why?
Immunity, Innate
1
2018
720
0.400
Why?
Lung Injury
2
2011
197
0.370
Why?
Mice, Inbred C57BL
15
2016
4689
0.350
Why?
Hydroxychloroquine
2
2020
54
0.350
Why?
Bacteria
1
2016
725
0.350
Why?
Smoking
2
2016
1380
0.340
Why?
Macrophages
1
2016
1261
0.330
Why?
Research Report
2
2021
75
0.330
Why?
Respiratory Insufficiency
2
2023
290
0.320
Why?
Bronchoalveolar Lavage Fluid
7
2013
590
0.310
Why?
Flow Cytometry
3
2018
1083
0.300
Why?
Epithelial Cells
4
2016
950
0.300
Why?
Wound Healing
1
2009
258
0.290
Why?
Mice
14
2018
14860
0.280
Why?
Inflammation Mediators
4
2016
477
0.280
Why?
Adult
13
2023
30528
0.280
Why?
Mice, Knockout
8
2015
2565
0.280
Why?
Hospitalization
4
2022
1749
0.280
Why?
Antiviral Agents
2
2023
645
0.270
Why?
Immunophenotyping
2
2018
274
0.260
Why?
Vaccination
1
2014
1204
0.260
Why?
Carotid Artery, Internal
1
2006
36
0.260
Why?
Carotid Artery Diseases
1
2006
57
0.250
Why?
Humans
35
2023
114623
0.250
Why?
Phagocytosis
2
2018
350
0.250
Why?
Animals
18
2018
31694
0.250
Why?
Intracranial Aneurysm
1
2006
91
0.240
Why?
Antibodies, Neutralizing
2
2022
221
0.230
Why?
Biomedical Research
2
2021
585
0.230
Why?
Lung Diseases
2
2021
701
0.230
Why?
Gene Expression Profiling
1
2009
1518
0.220
Why?
Public-Private Sector Partnerships
2
2021
43
0.210
Why?
Hypoxia
3
2014
957
0.200
Why?
Polycystic Kidney, Autosomal Dominant
1
2006
209
0.200
Why?
Ritonavir
1
2023
71
0.200
Why?
Pulmonary Circulation
2
2021
407
0.200
Why?
Antibodies, Monoclonal
3
2022
1262
0.200
Why?
Cytokines
3
2016
1840
0.190
Why?
Male
22
2023
55554
0.190
Why?
Cell Membrane Permeability
2
2012
83
0.180
Why?
Education
1
2021
95
0.180
Why?
Pulmonary Alveoli
3
2015
373
0.170
Why?
Tidal Volume
2
2018
75
0.170
Why?
Neutrophils
4
2015
1176
0.170
Why?
Triglycerides
2
2013
467
0.170
Why?
Antibodies
1
2021
371
0.170
Why?
Ventricular Function, Right
1
2021
250
0.160
Why?
Financing, Government
1
2019
40
0.160
Why?
Serum Bactericidal Test
1
2018
1
0.160
Why?
Pandemics
3
2022
1317
0.160
Why?
Rare Diseases
1
2019
89
0.150
Why?
Interinstitutional Relations
1
2018
54
0.150
Why?
Partial Pressure
1
2018
30
0.150
Why?
Vascular Diseases
1
2021
230
0.150
Why?
APACHE
1
2018
58
0.150
Why?
Systemic Inflammatory Response Syndrome
1
2018
70
0.150
Why?
Endothelial Cells
2
2016
681
0.150
Why?
Blood Gas Analysis
1
2018
72
0.150
Why?
Streptococcus
1
2018
22
0.150
Why?
Precision Medicine
1
2021
336
0.150
Why?
Disease Models, Animal
5
2015
3531
0.140
Why?
Betacoronavirus
1
2020
250
0.140
Why?
Macrophage Activation
1
2018
164
0.140
Why?
Goals
1
2018
147
0.140
Why?
Cell Separation
1
2018
291
0.140
Why?
Adoptive Transfer
3
2015
195
0.140
Why?
Soot
1
2016
16
0.130
Why?
Disease Susceptibility
1
2018
316
0.130
Why?
Critical Illness
2
2018
644
0.130
Why?
Lung Transplantation
1
2018
246
0.130
Why?
Research
1
2019
394
0.130
Why?
Chemokines
2
2015
216
0.130
Why?
Leukocytosis
1
2015
34
0.130
Why?
Aged
8
2022
19061
0.130
Why?
Pneumonia, Viral
1
2020
338
0.120
Why?
DNA Modification Methylases
1
2015
14
0.120
Why?
Coronavirus Infections
1
2020
330
0.120
Why?
Tissue and Organ Procurement
1
2018
228
0.120
Why?
Muscular Atrophy
2
2015
78
0.120
Why?
Wasting Syndrome
1
2015
11
0.120
Why?
Epithelium
1
2016
295
0.120
Why?
Nitric Oxide Synthase Type II
2
2012
157
0.120
Why?
Air Pollution, Indoor
1
2016
108
0.120
Why?
Particulate Matter
1
2016
185
0.120
Why?
Societies, Medical
1
2018
663
0.120
Why?
Ubiquitin-Protein Ligases
2
2015
139
0.120
Why?
Critical Care
1
2018
476
0.120
Why?
Interleukin-10
2
2014
299
0.120
Why?
Lipoprotein Lipase
2
2013
54
0.120
Why?
Intensive Care Units
1
2018
617
0.120
Why?
Muscle Proteins
2
2015
210
0.110
Why?
Azacitidine
1
2015
129
0.110
Why?
Osteomyelitis
1
2015
101
0.110
Why?
Cells, Cultured
4
2016
3881
0.110
Why?
Lipoproteins
2
2013
159
0.110
Why?
United States
8
2021
12176
0.110
Why?
Bacteremia
1
2015
160
0.110
Why?
Middle Aged
8
2023
26719
0.110
Why?
Colorado
1
2023
4099
0.110
Why?
Phenethylamines
1
2013
18
0.110
Why?
Adenosine A2 Receptor Agonists
1
2013
19
0.110
Why?
Air Pollutants
1
2016
242
0.110
Why?
Forkhead Transcription Factors
2
2015
170
0.110
Why?
Physical Conditioning, Animal
1
2015
194
0.110
Why?
Gene Knockout Techniques
1
2013
98
0.100
Why?
Sepsis
1
2018
509
0.100
Why?
Adaptive Clinical Trials as Topic
2
2022
19
0.100
Why?
Aquaporin 5
1
2012
2
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
923
0.100
Why?
Pulmonary Disease, Chronic Obstructive
2
2016
913
0.100
Why?
Time Factors
5
2016
6112
0.100
Why?
Enzyme Inhibitors
1
2015
750
0.100
Why?
Retrospective Studies
3
2023
12542
0.100
Why?
Cyclic Nucleotide Phosphodiesterases, Type 2
1
2011
1
0.100
Why?
Longitudinal Studies
1
2018
2387
0.090
Why?
Adenosine
1
2013
203
0.090
Why?
Staphylococcal Infections
1
2015
336
0.090
Why?
Exercise Therapy
1
2015
350
0.090
Why?
Capillary Permeability
1
2011
135
0.090
Why?
Treatment Outcome
5
2023
9084
0.090
Why?
Aftercare
2
2023
186
0.090
Why?
Biomarkers
2
2018
3408
0.090
Why?
Treatment Failure
2
2022
331
0.090
Why?
Severity of Illness Index
1
2018
2537
0.090
Why?
HIV-1
1
2016
768
0.090
Why?
Hypertension, Pulmonary
1
2021
1727
0.090
Why?
Genes, RAG-1
1
2009
11
0.090
Why?
Microtubules
1
2012
237
0.090
Why?
Leukocyte Reduction Procedures
1
2009
25
0.080
Why?
Monocytes
1
2012
502
0.080
Why?
Interleukin-2 Receptor alpha Subunit
1
2009
66
0.080
Why?
Leukocyte Count
1
2009
293
0.080
Why?
Heart Failure
1
2021
1945
0.080
Why?
Muscle, Skeletal
2
2015
1472
0.080
Why?
Cluster Analysis
1
2009
455
0.080
Why?
Gene Regulatory Networks
1
2009
228
0.080
Why?
Female
9
2023
59466
0.070
Why?
Sleep Apnea, Obstructive
1
2011
195
0.070
Why?
Interleukin-6
1
2011
676
0.070
Why?
Oligonucleotide Array Sequence Analysis
1
2009
740
0.070
Why?
Adipose Tissue
1
2011
539
0.070
Why?
T-Lymphocyte Subsets
1
2009
383
0.070
Why?
Patient Discharge
2
2023
771
0.070
Why?
Homeodomain Proteins
3
2015
463
0.060
Why?
Tomography, X-Ray Computed
2
2006
2279
0.060
Why?
Gene Expression Regulation
2
2012
2319
0.060
Why?
Receptors, CXCR4
2
2016
78
0.060
Why?
Sensitivity and Specificity
3
2018
1691
0.060
Why?
Tripartite Motif Proteins
2
2015
30
0.060
Why?
CD4-Positive T-Lymphocytes
1
2009
959
0.060
Why?
Nucleocapsid
1
2022
17
0.050
Why?
Clinical Trials, Phase II as Topic
1
2022
59
0.050
Why?
Angiopoietins
2
2013
12
0.050
Why?
Cell Line, Transformed
2
2012
133
0.050
Why?
HIV Infections
1
2016
2469
0.050
Why?
Epigenomics
1
2022
101
0.050
Why?
Granulomatosis with Polyangiitis
1
2002
41
0.050
Why?
Phenotype
2
2022
2796
0.050
Why?
Prospective Studies
3
2023
6217
0.050
Why?
Blotting, Western
2
2016
1147
0.050
Why?
Multicenter Studies as Topic
1
2022
248
0.050
Why?
National Institutes of Health (U.S.)
1
2021
106
0.050
Why?
Cohort Studies
2
2023
4894
0.050
Why?
Random Allocation
2
2012
335
0.050
Why?
User-Computer Interface
1
2002
140
0.050
Why?
Review Literature as Topic
1
2021
61
0.050
Why?
Macrophages, Peritoneal
2
2012
93
0.050
Why?
Drug Discovery
1
2021
123
0.050
Why?
Antimalarials
1
2020
24
0.040
Why?
Bayes Theorem
1
2022
329
0.040
Why?
Bronchoscopy
1
2002
245
0.040
Why?
Single-Blind Method
1
2020
258
0.040
Why?
Antibodies, Viral
1
2023
520
0.040
Why?
Airway Obstruction
1
2002
168
0.040
Why?
Netherlands
1
2018
64
0.040
Why?
Ventricular Dysfunction, Right
1
2021
217
0.040
Why?
Epigenesis, Genetic
1
2022
520
0.040
Why?
Inflammation
3
2015
2477
0.040
Why?
Clinical Trials as Topic
1
2022
931
0.040
Why?
Image Processing, Computer-Assisted
1
2002
682
0.040
Why?
Risk Factors
2
2022
8628
0.040
Why?
Computational Biology
1
2021
530
0.040
Why?
ROC Curve
1
2018
442
0.040
Why?
Congresses as Topic
1
2018
195
0.030
Why?
Bacterial Infections
1
2018
218
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1842
0.030
Why?
Virus Diseases
1
2018
194
0.030
Why?
Graft Survival
1
2018
446
0.030
Why?
Cooperative Behavior
1
2018
381
0.030
Why?
Cell Count
1
2016
303
0.030
Why?
Receptors, Granulocyte Colony-Stimulating Factor
1
2015
1
0.030
Why?
Intercellular Adhesion Molecule-1
1
2016
154
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
157
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2015
71
0.030
Why?
Chemotaxis, Leukocyte
1
2015
130
0.030
Why?
Microscopy, Confocal
1
2016
304
0.030
Why?
Magnetic Resonance Imaging
1
2006
3039
0.030
Why?
Cadherins
1
2016
175
0.030
Why?
Respiratory Function Tests
1
2016
522
0.030
Why?
Environmental Monitoring
1
2016
254
0.030
Why?
Sputum
1
2016
285
0.030
Why?
Diagnosis, Differential
1
2018
1342
0.030
Why?
Cell Lineage
1
2016
309
0.030
Why?
Immunocompromised Host
1
2015
195
0.030
Why?
Influenza A Virus, H1N1 Subtype
1
2015
139
0.030
Why?
Host-Pathogen Interactions
1
2016
295
0.030
Why?
Adipose Tissue, White
1
2013
27
0.030
Why?
Cell Survival
1
2016
1020
0.030
Why?
Benzylamines
1
2012
39
0.030
Why?
Adipose Tissue, Brown
1
2013
43
0.030
Why?
Mice, Congenic
1
2012
21
0.030
Why?
B7-2 Antigen
1
2012
25
0.030
Why?
Heterocyclic Compounds
1
2012
18
0.030
Why?
Chemokine CXCL12
1
2012
74
0.030
Why?
RING Finger Domains
1
2012
2
0.030
Why?
Cross-Sectional Studies
1
2022
4405
0.030
Why?
Quality of Life
1
2023
2353
0.020
Why?
Diet, Atherogenic
1
2011
6
0.020
Why?
Chylomicrons
1
2011
6
0.020
Why?
Ventilators, Mechanical
1
2011
52
0.020
Why?
Lipoproteins, VLDL
1
2011
21
0.020
Why?
Myofibroblasts
1
2012
116
0.020
Why?
Cyclic GMP
1
2011
80
0.020
Why?
Gene Expression
1
2016
1421
0.020
Why?
Ventilator-Induced Lung Injury
1
2011
49
0.020
Why?
Cyclic AMP
1
2011
227
0.020
Why?
Adenoviridae
1
2011
184
0.020
Why?
Obesity
1
2022
2507
0.020
Why?
Motor Activity
1
2015
640
0.020
Why?
Cardiovascular Diseases
1
2021
1727
0.020
Why?
Down-Regulation
1
2012
594
0.020
Why?
Risk Assessment
1
2018
2967
0.020
Why?
Trachea
1
2011
224
0.020
Why?
Muscle Strength
1
2012
270
0.020
Why?
RNA, Small Interfering
1
2011
535
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
498
0.020
Why?
Multivariate Analysis
1
2012
1430
0.020
Why?
Fibroblasts
1
2012
837
0.020
Why?
Postoperative Complications
1
2018
2128
0.020
Why?
Respiration, Artificial
1
2011
529
0.020
Why?
Immunohistochemistry
1
2012
1629
0.020
Why?
Aged, 80 and over
1
2018
6344
0.020
Why?
Cell Line
1
2012
2635
0.020
Why?
Anti-Bacterial Agents
1
2015
1477
0.020
Why?
Survival Rate
1
2009
1644
0.020
Why?
Cell Proliferation
1
2012
2186
0.020
Why?
Proteins
1
2011
908
0.020
Why?
Randomized Controlled Trials as Topic
1
2009
1214
0.010
Why?
RNA, Messenger
1
2011
2552
0.010
Why?
Bronchography
1
2002
9
0.010
Why?
Blood Glucose
1
2011
1819
0.010
Why?
Tracheal Stenosis
1
2002
24
0.010
Why?
Insulin
1
2011
2076
0.010
Why?
Observer Variation
1
2002
295
0.010
Why?
Signal Transduction
1
2012
4509
0.010
Why?
Aggarwal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)